Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. Our mission is to improve the human condition by investing our capital and expertise to create value for the most promising life science companies.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions